Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19

Effective therapies for patients with coronavirus disease 2019 (COVID-19) are needed, and clinical trial data have demonstrated that low-dose dexamethasone reduced mortality in hospitalized patients with COVID-19 who required respiratory support.To estimate the association between administration of corticosteroids compared with usual care or placebo and 28-day all-cause mortality.Prospective meta-analysis that pooled data from 7 randomized...